Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 7;12(3):386.
doi: 10.3390/life12030386.

Obtaining Reliable RT-qPCR Results in Molecular Diagnostics-MIQE Goals and Pitfalls for Transcriptional Biomarker Discovery

Christian Grätz  1   2 , Maria L U Bui  1   2 , Granit Thaqi  1 , Benedikt Kirchner  1   2 , Robert P Loewe  2 , Michael W Pfaffl  1
Affiliations
Review

Obtaining Reliable RT-qPCR Results in Molecular Diagnostics-MIQE Goals and Pitfalls for Transcriptional Biomarker Discovery

Christian Grätz et al. Life (Basel). .

Abstract

In this review, we discuss the development pipeline for transcriptional biomarkers in molecular diagnostics and stress the importance of a reliable gene transcript quantification strategy. Hence, a further focus is put on the MIQE guidelines and how to adapt them for biomarker discovery, from signature validation up to routine diagnostic applications. First, the advantages and pitfalls of the holistic RNA sequencing for biomarker development will be described to establish a candidate biomarker signature. Sequentially, the RT-qPCR confirmation process will be discussed to validate the discovered biomarker signature. Examples for the successful application of RT-qPCR as a fast and reproducible quantification method in routinemolecular diagnostics are provided. Based on the MIQE guidelines, the importance of "key steps" in RT-qPCR is accurately described, e.g., reverse transcription, proper reference gene selection and, finally, the application of automated RT-qPCR data analysis software. In conclusion, RT-qPCR proves to be a valuable tool in the establishment of a disease-specific transcriptional biomarker signature and will have a great future in molecular diagnostics or personalized medicine.

Keywords: MIQE; RT-qPCR; biomarker signature; molecular diagnostics; transcriptional biomarkers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Pfaffl M.W. Transcriptional biomarkers. Methods. 2013;59:1–2. doi: 10.1016/j.ymeth.2012.12.011. - DOI - PubMed
    1. FDA-NIH Biomarker Working Group BEST (Biomarkers, EndpointS, and Other Tools) Resource. [(accessed on 22 December 2021)]; Available online: https://www.ncbi.nlm.nih.gov/books/NBK326791/ - PubMed
    1. Riedmaier I., Pfaffl M.W. Transcriptional biomarkers—High throughput screening, quantitative verification, and bioinformatical validation methods. Methods. 2013;59:3–9. doi: 10.1016/j.ymeth.2012.08.012. - DOI - PubMed
    1. Hong L.Z., Zhou L., Zou R., Khoo C.M., Chew A.L.S., Chin C.L., Shih S.J. Systematic evaluation of multiple qPCR platforms, NanoString and miRNA-Seq for microRNA biomarker discovery in human biofluids. Sci. Rep. 2021;11:1–11. doi: 10.1038/s41598-021-83365-z. - DOI - PMC - PubMed
    1. Ignatiadis M., Sledge G.W., Jeffrey S.S. Liquid biopsy enters the clinic—Implementation issues and future challenges. Nat. Rev. Clin. Oncol. 2021;18:297–312. doi: 10.1038/s41571-020-00457-x. - DOI - PubMed

LinkOut - more resources